Vanguard Asset Management
IART icon

Vanguard Asset Management’s Integra LifeSciences IART Stock Holding History

Vanguard Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$849K Hold
52,122
– – ﹤0.01% 1937
2026
Q2 		$936K Buy
52,122
+12,306
+31% +$172K ﹤0.01% 1910
2026
Q1 		$375K Buy
+39,816
New +$437K ﹤0.01% 2222

Other funds holding IART

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Paradigm Capital Management Inc
Paradigm Capital Management Inc Albany, New York $3.17B AUM 63.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

Vanguard Asset Management's IART Position: Q3 2026 in Review

Vanguard Asset Management held its Integra LifeSciences (IART) position steady in Q3 2026 at 52,122 shares worth $849K. The position accounts for ﹤0.01% of the portfolio, ranked #1937.

Vanguard Asset Management first reported a position in IART in Q1 2026 and has held it in 3 quarters since. The position peaked at $936K in Q2 2026. 179 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Vanguard Asset Management held 52,122 shares of Integra LifeSciences worth $849K as of Q3 2026.
  • Vanguard Asset Management left its Integra LifeSciences share count unchanged in Q3 2026.
  • Integra LifeSciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1937 holding.
  • Vanguard Asset Management first reported a position in Integra LifeSciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Integra LifeSciences position peaked at $936K in Q2 2026.
  • 179 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.